| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/06/2002 | US20020068059 Modified human C3 protein for forming said convertase; use in depleting levels of complement pathway protein; preventing transplant rejection |
| 06/06/2002 | US20020068058 Autoantibody inhibitors |
| 06/06/2002 | US20020068047 Treating a wound with an invasion inducing agent such as peptides containing PHSRN sequence |
| 06/06/2002 | US20020068044 Natural killer cell lines and methods of use |
| 06/06/2002 | US20020068043 Fusion protein, comprising a receptor-antagonizing domain (such as prolactin receptor antagonist) and a positive immunomodulator domain (such as an interleukin); combines apoptosis induction and immunotherapy |
| 06/06/2002 | EP1144454A3 Modified peptides as therapeutic agents |
| 06/06/2002 | DE10130849A1 Transfection using complex of plasmid, peptide and lipid, are useful in medicine, where the peptide comprises oligolysine sequence |
| 06/06/2002 | DE10059630A1 Arzneimittel zur Vermeidung oder Behandlung von durch humanen Papillomavirus-Typ 18-hervorgerufenem Tumor Medicines used to prevent or treat by human papillomavirus type 18-evoked tumor |
| 06/06/2002 | DE10058907A1 New nucleic acid encoding soluble cytokine receptor, useful for diagnosis and treatment of e.g. immune disease, also related protein and antibodies |
| 06/06/2002 | DE10058596A1 Verfahren zum Screening von chemischen Verbindungen zur Modulierung der Wechselwirkung einer EVH1-Domäne oder eines Proteins mit einer EVH1-Domäne mit einer EVH1-Bindedomäne oder einem Protein mit einer EVH1-Bindedomäne sowie ein Verfahren zum Nachweis besagter Wechselwirkung Method for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1-binding domain or a protein having an EVH1-binding domain and a method for the detection of said interaction |
| 06/06/2002 | DE10055789A1 DNA-Sequenz und Microcin aus Escherichia coli StammDSM 6601 DNA sequence and Microcin from Escherichia coli 6601 StammDSM |
| 06/06/2002 | DE10055285A1 Neue Marker für die Diagnose und Therapie von Tumoren New marker for the diagnosis and therapy of tumors |
| 06/06/2002 | DE10053047A1 Use of caveolin polypeptide or caveolin nucleic acid for treating cell proliferation-associated disorder e.g., cancer such as non-steroid dependent carcinoma, stomach carcinoma or colon carcinoma |
| 06/06/2002 | CA2604066A1 Compositions and methods for diagnosing or treating psoriasis |
| 06/06/2002 | CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | CA2436903A1 Immunotherapeutic methods and molecules |
| 06/06/2002 | CA2436778A1 Floral development genes |
| 06/06/2002 | CA2433665A1 Projection against mycobacterial infections |
| 06/06/2002 | CA2431837A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | CA2430745A1 Master bone formation transcription factor: compositions and methods of use |
| 06/06/2002 | CA2430584A1 Novel nucleic acids and polypeptides |
| 06/06/2002 | CA2430559A1 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | CA2430528A1 Hybrid antibodies |
| 06/06/2002 | CA2430526A1 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | CA2430485A1 Cytonkine receptor zcytor19 |
| 06/06/2002 | CA2430378A1 Substrate linked directed evolution (slide) |
| 06/06/2002 | CA2430365A1 Neurotoxins with enhanced target specificity |
| 06/06/2002 | CA2430351A1 Human protooncogene and protein encoded therein |
| 06/06/2002 | CA2430331A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/06/2002 | CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | CA2430084A1 Obp1:a protein selectively expressed in osteoblasts |
| 06/06/2002 | CA2430082A1 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | CA2429819A1 Cytokine-like proteins |
| 06/06/2002 | CA2429816A1 Sulfonated diarylrhodamine dyes as fluorescent labels |
| 06/06/2002 | CA2429599A1 Use of b7rp1 antagonists in ige-mediated disorders |
| 06/06/2002 | CA2428595A1 Staphylococcus aureus protein staau_r2, gene encoding it and uses thereof |
| 06/06/2002 | CA2428552A1 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 06/06/2002 | CA2425872A1 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/05/2002 | EP1211319A2 Gene transfer into pancreatic and biliary epithelial cells |
| 06/05/2002 | EP1211318A1 Paramyxoviruses comprising modified transcription start sequence |
| 06/05/2002 | EP1211317A1 Gene encoding protein participating in signal transduction of cytokinin |
| 06/05/2002 | EP1211315A1 Recombinant vectors for producing HCV envelope proteins |
| 06/05/2002 | EP1211314A2 Expression of a human insulin precursor in p. pastoris |
| 06/05/2002 | EP1211261A2 Stable polymerized hemoglobin blood-substitute |
| 06/05/2002 | EP1211260A1 Peptides from Ag85 of mycobacterium and uses thereof |
| 06/05/2002 | EP1210874A1 Alpha-tocopherol transport protein knockout animal |
| 06/05/2002 | EP1210869A1 Construction of barley with decreased gel protein content |
| 06/05/2002 | EP1210724A1 Method of determining etch endpoint using principal components analysis of optical emission spectra |
| 06/05/2002 | EP1210606A1 Cartilage resorption assays |
| 06/05/2002 | EP1210605A2 Analysis and treatment of body weight and eating disorders |
| 06/05/2002 | EP1210595A1 System for monitoring the expression and/or location of transgenes |
| 06/05/2002 | EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210456A1 Antibiotics based upon bacteriophage lysis proteins |
| 06/05/2002 | EP1210447A2 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules |
| 06/05/2002 | EP1210445A2 Recombinant microorganisms |
| 06/05/2002 | EP1210444A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 06/05/2002 | EP1210438A2 Ehrlichia canis genes and vaccines |
| 06/05/2002 | EP1210436A2 Male sterile plants |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210434A2 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 06/05/2002 | EP1210433A2 Methods and compositions of a novel serine protease inhibitor |
| 06/05/2002 | EP1210431A1 Hepatocyte nuclear factor 4-gamma: hnf4-gamma. |
| 06/05/2002 | EP1210430A2 Muc-1 derived peptides |
| 06/05/2002 | EP1210429A2 Apoptosis proteins |
| 06/05/2002 | EP1210428A1 Pd-1, a receptor for b7-4, and uses therefor |
| 06/05/2002 | EP1210427A1 Human narcolepsy gene |
| 06/05/2002 | EP1210426A2 Polymorphisms in a klotho gene |
| 06/05/2002 | EP1210425A2 Baff receptor (bcma), an immunoregulatory agent |
| 06/05/2002 | EP1210424A1 Novel b7-4 molecules and uses therefor |
| 06/05/2002 | EP1210423A1 Novel abc transporter and uses thereof |
| 06/05/2002 | EP1210422A2 Human abc2 transporter and uses thereof |
| 06/05/2002 | EP1210421A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 06/05/2002 | EP1210420A1 Cd154 ligand, and recombinant cells expressing it |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210418A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/05/2002 | EP1210416A2 Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses |
| 06/05/2002 | EP1210408A2 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 06/05/2002 | EP1210405A2 Cardiomyocytes with enhanced proliferative potential, and methods for preparing and using same |
| 06/05/2002 | EP1210375A1 Recombinant proteins and molecular complexes derived therefrom, analogous to molecules involved in immune responses |
| 06/05/2002 | EP1210373A2 Congener independent detection of microcystin and nodularin congeners |
| 06/05/2002 | EP1210372A2 Human monoclonal antibodies to her2/neu |
| 06/05/2002 | EP1210370A1 Human tumor necrosis factor receptor tr16 |
| 06/05/2002 | EP1210369A1 Monomeric analogues of human insulin |
| 06/05/2002 | EP1210368A2 Use of semaphorin for modulation of cellular efflux |
| 06/05/2002 | EP1210367A1 Sequence derived from a human mammary gland cdna library |
| 06/05/2002 | EP1210366A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 06/05/2002 | EP1210365A2 Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus |
| 06/05/2002 | EP1210364A1 Vaccine antigens of moraxella |
| 06/05/2002 | EP1210363A2 Novel angiopoietin materials and methods |
| 06/05/2002 | EP1210355A2 Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 06/05/2002 | EP1210120A1 Nerve cell growth modulators (amphibodies) |
| 06/05/2002 | EP1210112A2 Vaccine against hbv and hpv |
| 06/05/2002 | EP1210111A1 Gamma-herpesvirus dna and methods of use |
| 06/05/2002 | EP1210110A1 Prion protein binding proteins and uses thereof |
| 06/05/2002 | EP1210102A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/05/2002 | EP1210098A1 Enhancement of peptide cellular uptake |
| 06/05/2002 | EP1209969A2 Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders |
| 06/05/2002 | EP1209968A1 Transgenic mammal capable of facilitating production of donor-specific functional immunity |
| 06/05/2002 | EP1121144B1 Stable concentrated insulin preparations for pulmonary delivery |